| Dr Anahita M Parsee, MD | |
|
2005 Technology Pkwy Ste 300, Mechanicsburg, PA 17050-9423 | |
| (717) 231-8555 | |
| Not Available |
| Full Name | Dr Anahita M Parsee |
|---|---|
| Gender | Female |
| Speciality | Thoracic Surgery (cardiothoracic Vascular Surgery) |
| Location | 2005 Technology Pkwy Ste 300, Mechanicsburg, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508029489 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | MD467785 (Pennsylvania) | Primary |
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Health care workers must diagnose and isolate Ebola victims at an early stage to have a chance to save them and prevent the virus from spreading. But the most sensitive and quickest diagnostic test produces a small percentage of false negative results that undermine efforts to control the deadly agent.
MannKind Corporation today reported financial results for the fourth quarter and year ended December 31, 2011.
Increasing its ability to provide patients with the highest quality of care, Piedmont Hospital in Atlanta has installed the country's first InfinixTM VF-i vascular X-ray system with the 12" x 12" mid-sized flat panel detector (FPD) from Toshiba America Medical Systems, Inc. The new mid-sized FPD system is equipped with Toshiba's Next Generation Advanced Image Processing (AIP) capabilities and marks the fourth Toshiba Infinix-i system installed by Piedmont Hospital.
Genentech, a member of the Roche Group, today announced positive results from Stage 1 of CLL11, a Phase III randomized study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab (GA101) plus chlorambucil chemotherapy compared with chlorambucil alone in people with previously untreated chronic lymphocytic leukemia (CLL).
A team of scientists led by researchers at the University of Massachusetts Medical School and the University of Miami Miller School of Medicine have identified what is likely a key genetic pathway underlying bipolar (manic depressive) disorder, a breakthrough that could lead to better drugs for treating bipolar affective disorder, as well as depression and other related mood disorders.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anahita M Parsee, MD 2500 Bernville Rd, Reading, PA 19605-9453 Ph: (610) 378-2000 | Dr Anahita M Parsee, MD 2005 Technology Pkwy Ste 300, Mechanicsburg, PA 17050-9423 Ph: (717) 231-8555 |
News Archive
Health care workers must diagnose and isolate Ebola victims at an early stage to have a chance to save them and prevent the virus from spreading. But the most sensitive and quickest diagnostic test produces a small percentage of false negative results that undermine efforts to control the deadly agent.
MannKind Corporation today reported financial results for the fourth quarter and year ended December 31, 2011.
Increasing its ability to provide patients with the highest quality of care, Piedmont Hospital in Atlanta has installed the country's first InfinixTM VF-i vascular X-ray system with the 12" x 12" mid-sized flat panel detector (FPD) from Toshiba America Medical Systems, Inc. The new mid-sized FPD system is equipped with Toshiba's Next Generation Advanced Image Processing (AIP) capabilities and marks the fourth Toshiba Infinix-i system installed by Piedmont Hospital.
Genentech, a member of the Roche Group, today announced positive results from Stage 1 of CLL11, a Phase III randomized study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab (GA101) plus chlorambucil chemotherapy compared with chlorambucil alone in people with previously untreated chronic lymphocytic leukemia (CLL).
A team of scientists led by researchers at the University of Massachusetts Medical School and the University of Miami Miller School of Medicine have identified what is likely a key genetic pathway underlying bipolar (manic depressive) disorder, a breakthrough that could lead to better drugs for treating bipolar affective disorder, as well as depression and other related mood disorders.
› Verified 1 days ago
Dr. Troy Allen Moritz, D.O. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2005 Technology Pkwy Ste 300, Mechanicsburg, PA 17050 Phone: 717-231-8555 Fax: 717-231-8568 |